London
· Delayed Price · Currency is GBP · Price in USD Ionis Pharmaceuticals Statistics
Total Valuation
LON:0JDI has a market cap or net worth of GBP 4.06 billion. The enterprise value is 3.79 billion.
| Market Cap | 4.06B |
| Enterprise Value | 3.79B |
Important Dates
The last earnings date was Wednesday, February 19, 2025.
| Earnings Date | Feb 19, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +4.42% |
| Shares Change (QoQ) | +6.33% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 157.59M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 8.65 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -10.46 |
| EV / Sales | 6.80 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -8.69 |
Financial Position
The company has a current ratio of 8.47, with a Debt / Equity ratio of 3.33.
| Current Ratio | 8.47 |
| Quick Ratio | 7.74 |
| Debt / Equity | 3.33 |
| Debt / EBITDA | n/a |
| Debt / FCF | -3.59 |
| Interest Coverage | -5.25 |
Financial Efficiency
Return on equity (ROE) is -93.10% and return on invested capital (ROIC) is -12.12%.
| Return on Equity (ROE) | -93.10% |
| Return on Assets (ROA) | -9.91% |
| Return on Invested Capital (ROIC) | -12.12% |
| Return on Capital Employed (ROCE) | -17.63% |
| Revenue Per Employee | 526,888 |
| Profits Per Employee | -339,157 |
| Employee Count | 927 |
| Asset Turnover | 0.24 |
| Inventory Turnover | 91.49 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -26.14% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -26.14% |
| 50-Day Moving Average | 34.14 |
| 200-Day Moving Average | 40.06 |
| Relative Strength Index (RSI) | 48.88 |
| Average Volume (20 Days) | 749 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 7.52 |
Income Statement
In the last 12 months, LON:0JDI had revenue of GBP 563.24 million and -362.56 million in losses. Loss per share was -2.42.
| Revenue | 563.24M |
| Gross Profit | -165.83M |
| Operating Income | -379.48M |
| Pretax Income | -367.49M |
| Net Income | -362.56M |
| EBITDA | -369.94M |
| EBIT | -379.48M |
| Loss Per Share | -2.42 |
Balance Sheet
The company has 1.84 billion in cash and 1.56 billion in debt, giving a net cash position of 274.89 million.
| Cash & Cash Equivalents | 1.84B |
| Total Debt | 1.56B |
| Net Cash | 274.89M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 469.96M |
| Book Value Per Share | 2.98 |
| Working Capital | 1.85B |
Cash Flow
In the last 12 months, operating cash flow was -400.14 million and capital expenditures -36.17 million, giving a free cash flow of -436.31 million.
| Operating Cash Flow | -400.14M |
| Capital Expenditures | -36.17M |
| Free Cash Flow | -436.31M |
| FCF Per Share | n/a |
Margins
Gross margin is -29.44%, with operating and profit margins of -67.37% and -64.37%.
| Gross Margin | -29.44% |
| Operating Margin | -67.37% |
| Pretax Margin | -65.25% |
| Profit Margin | -64.37% |
| EBITDA Margin | -65.68% |
| EBIT Margin | -67.37% |
| FCF Margin | n/a |
Dividends & Yields
LON:0JDI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.42% |
| Shareholder Yield | -4.42% |
| Earnings Yield | -8.92% |
| FCF Yield | -10.74% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
LON:0JDI has an Altman Z-Score of 1.18. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.18 |
| Piotroski F-Score | n/a |